Immunology research
KPV 5 mg
A tripeptide fragment of alpha-MSH studied in preclinical inflammation and mucosal immunity research.
What it is
KPV is the lysine-proline-valine tripeptide, a C-terminal fragment of alpha-melanocyte-stimulating hormone. It is a research compound, not a registered medicine.
Mechanism being studied
Preclinical work describes anti-inflammatory signalling effects, including modulation of NF-kB-related pathways in cell and animal models.
Human evidence
Controlled human evidence is not available. Claims relating to inflammatory or gastrointestinal conditions are not supported for clinical use.
Safety considerations
Safety information for this compound is incomplete outside of controlled settings. Reported considerations in the literature include injection-site reactions, unknown long-term effects, product-quality and sterility risks with unregistered preparations, and unpredictable interactions with existing medicines or conditions. Any consideration of use belongs with a registered healthcare professional who can assess the individual clinical picture.
Regulatory status
Research-only. Not approved for human therapeutic use. Confirm local rules.
Key references
- Preclinical immunology literature indexed under 'KPV peptide'.
- SAHPRA — unregistered health product guidance.
References are provided as reading directions for professionals. They do not constitute endorsement of any use.
Information only — availability subject to applicable law, prescription/authorisation, and licensed healthcare/pharmacy channels. Nothing on this page is an offer to sell, and no dosing or self-administration guidance is provided.
South Africa — compliance notice
SAHPRA has publicly warned about unregistered peptide products being marketed to the South African public. In general, products intended to diagnose, treat, or otherwise alter bodily functions require registration or authorisation before they may lawfully be sold. ELLIVON BIOSCIENCES publishes reference information only and directs all clinical questions to registered healthcare professionals and licensed pharmacy channels.